Abstract:Cardiovascular diseases are among the major causes of mortality among aged people in most developed countries. Oxidative stress, which causes mutations of mitochondrial DNA and mitochondrial dysfunctions, was considered as the main mechanism of heart failure and other pathologies of old age. However, in recent years the prior paradigm of mechanisms of aging, oxidative stress and antioxidative defense was questioned and in some aspects even turned out to be wrong. In this review, we discuss the new data that led to the need to reconsider paradigms. We show that although the mitochondrial free radical theory of aging remains valid, the radical responsible for the aging is the protonated form of the superoxide radical, namely perhydroxyl radical, which was largely ignored all previous years. Perhydroxyl radical initiates the isoprostane pathway of lipid peroxidation (IPLP) of polyunsaturated fatty acids, which are part of the phospholipid core of the mitochondrial inner membrane. IPLP was discovered 30 years ago by Roberts and Morrow at the Vanderbilt University, but the mechanism of its initiation remained unknown. The IPLP causes formation of the racemic mixture of hundreds of biologically active products, named isoprostanes, and highly toxic molecules, first of all isolevuglandins. We distinguish two types of damages caused by IPLP during aging. The first one is associated with oxidative damages to cardiolipin and phosphatidylethanolamine (PEA), which result in disruption of polyenzymatic complexes of the oxidative phosphorylation system. The second type of dysfunctions is caused by the direct actions of toxic products on the lysine-containing proteins and PEA. To this type of mitochondrial damages evidently belongs the oxidative damage of the mitochondrial DNA polymerase, which results in a 20-fold increase in mutations of mitochondrial mtDNA.

Mitochondrial Aging and Age-Related Dysfunction of Mitochondria

Oxidative Stress, Mitochondrial DNA Mutation, and Impairment of Antioxidant Enzymes in Aging 1

Mitochondrial dysfunction and its association with age-related disorders

Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases

Mitophagy, Diseases, and Aging

Mitophagy: An Emerging Role in Aging and Age-Associated Diseases

Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction

Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue

Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging.

Mitochondrial and metabolic dysfunction in ageing and age-related diseases

The Mitochondrial Production of Reactive Oxygen Species in Relation to Aging and Pathology

Mitochondrial abnormalities in muscle and other aging cells: Classification, causes, and effects

Mitochondria: Aging, Metabolic Syndrome and Cardiovascular Diseases. Formation of a New Paradigm

Anti-Aging Medicine: Mitochondria-Targeted Antioxidants and Physical Activity

Role of mitochondria in oxidative stress and aging

Mitophagy, Mitochondrial Dynamics, and Homeostasis in Cardiovascular Aging

Mitochondrial Function in Ageing: Coordination with Signalling and Transcriptional Pathways.

Mitophagy in relation to chronic inflammation/ROS in aging

Mitochondria Damage Checkpoint, Aging, and Cancer

The role of mitochondrial dysfunction in age-related diseases

Modulation of Mitochondrial Function in Elderly Brain: Involvement of Autophagy and Apoptosis